Home › Funds › Tetragon Partners GP Ltd › GLUE
Tetragon Partners GP Ltd position in GLUE
MONTE ROSA THERAPEUTICS INC · Health Care
Tetragon Partners GP Ltd reported holding 56,052 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.4M, representing 0.22% of its reported portfolio and ranking #34 among its reported holdings. Tetragon Partners GP Ltd first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tetragon Partners GP Ltd's GLUE position evolved
Tetragon Partners GP Ltd first disclosed a stake in GLUE in Q2 2026 at 56,052 shares (US$1.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 56.05K | $1.36M | New |
About GLUE and 13F data
GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 74 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GLUE
- NEA Management Company, LLC 7.69M sh · $186.15M · Q2 2026
- TCG Crossover Management, LLC 4.62M sh · $111.86M · Q2 2026
- Vestal Point Capital, LP 4.60M sh · $111.32M · Q2 2026
- BVF INC/IL 4.46M sh · $107.95M · Q2 2026
- BAKER BROS. ADVISORS LP 4.35M sh · $105.17M · Q2 2026
- MONTANOVA CAPITAL, LLC 3.55M sh · $85.90M · Q2 2026
- Versant Venture Management, LLC 3.18M sh · $76.97M · Q2 2026
- BRAIDWELL LP 2.45M sh · $59.33M · Q2 2026
- Aisling Capital Management LP 1.56M sh · $37.65M · Q2 2026
- Bellevue Group AG 1.19M sh · $28.80M · Q2 2026
- MPM BioImpact LLC 1.16M sh · $28.10M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.00M sh · $24.20M · Q2 2026
More on Tetragon Partners GP Ltd
FAQ
How long has Tetragon Partners GP Ltd held GLUE?
Tetragon Partners GP Ltd has disclosed GLUE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Tetragon Partners GP Ltd's current position in GLUE?
As of Q2 2026, Tetragon Partners GP Ltd holds 56.05K shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $1.36M, representing 0.22% of its reported portfolio and ranking #34.
Has Tetragon Partners GP Ltd been buying or selling GLUE?
In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd newly opened its position in GLUE.
Which other funds hold GLUE?
Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.